பைன் மூலதனம் பொது பங்கு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பைன் மூலதனம் பொது பங்கு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பைன் மூலதனம் பொது பங்கு Today - Breaking & Trending Today

Ginkgo's Insanely Great $15B Deal, The Who & How Behind Biggest Sector Deal Ever : Biofuels Digest


In Massachusetts, Ginkgo Bioworks and Soaring Eagle Acquisition Corp. have agreed to a business combination that will result in Ginkgo becoming a publicly-listed company. The transaction is expected to close in the third quarter of 2021.
The $15B valuation and $2.5B to Ginkgo in proceeds
The transaction implies a pre-money equity valuation for Ginkgo of $15.0 billion, and is expected to provide up to $2.5 billion of gross cash proceeds. Gross proceeds include Soaring Eagle’s $1.725 billion of cash in trust (subject to any redemptions by Soaring Eagle’s public shareholders) and $775 million in proceeds from a PIPE transaction priced at $10.00 per share of Class A common stock of Soaring Eagle to be funded immediately prior to the closing of the transaction.  ....

United States , Tom Knight , Shyam Sankar , Christian Henry , Baillie Gifford , Pacific Biosciences , Barry Canton , Reshma Shetty , Harrye Sloan , Austin Che , Jason Kelly , Arie Belldegrun , Harry Sloan , Ginkgo Bioworks Holdings Inc , Eagle Acquisition Corp , Investment Management , Ginkgo Bioworks Inc , T Rowe Price Associates Inc , Putnam Investments , Mckinsey Global Institute , Ginkgo Bioworks , Soaring Eagle Acquisition , Soaring Eagle , Equity Partners , Bellco Capital , Kite Pharma ,

Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming


Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming
Ginkgo is building the leading horizontal platform for synthetic biology, making it possible to program cells as easily as we can program computers and enabling innovation across industries, including therapeutics, industrials, food and agriculture
News provided by
Share this article
BOSTON and LOS ANGELES, May 11, 2021 /PRNewswire/
Business combination with Soaring Eagle Acquisition Corp. (Nasdaq:SRNG) values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds.
Institutional investors have committed $775 million in an oversubscribed PIPE, with anchor investments from Baillie Gifford, Putnam Investments, and funds and accounts managed by Counterpoint Global (Morgan Stanley Investment Management). New investors including accounts advised by ARK Investment Management LLC, ArrowMark P ....

New York , United States , Jeff Sagansky , Rosen Katz , Tom Knight , Shyam Sankar , Christian Henry , Keli Baker , Baillie Gifford , Pacific Biosciences , Barry Canton , Reshma Shetty , Harrye Sloan , Austin Che , Jason Kelly , Arie Belldegrun , Harry Sloan , Ginkgo Bioworks Holdings Inc , Eagle Acquisition Corp , Investment Management , Ginkgo Bioworks Inc , Mckinsey Global Institute , Morgan Stanley Co , White Case , Investment Group , Latham Watkins ,

Synbio Powerhouse Ginkgo Bioworks Goes Public in $17.5B SPAC Deal


Synbio Powerhouse Ginkgo Bioworks Goes Public in $17.5B SPAC Deal
May 11, 2021
Synthetic biology powerhouse Ginkgo Bioworks will become a public company through a $17.5 billion merger with a special purpose acquisition company (SPAC) that is expected to provide up to $2.5 billion of gross cash proceeds. [Ginkgo Bioworks]
Share
Synthetic biology powerhouse Ginkgo Bioworks said today it will become a public company through a $17.5 billion merger with a special purpose acquisition company (SPAC) that is expected to provide up to $2.5 billion of gross cash proceeds.
The SPAC business combination with Soaring Eagle Acquisition Corp. implies a pre-money equity valuation of $15 billion for Ginkgo, the company said. Soaring Eagle will change its name to Ginkgo Bioworks Holdings, change its jurisdiction of formation to Delaware and change its ticker symbol from SRNG to a new symbol. ....

United States , Tom Knight , Shyam Sankar , Christian Henry , Baillie Gifford , Pacific Biosciences , Barry Canton , Reshma Shetty , Austin Che , Jason Kelly , Arie Belldegrun , Harry Sloan , Artificial Intelligence Laboratory , Gilead Sciences , Eagle Acquisition Corp , Investment Group , Ginkgo Bioworks Holdings , Investment Management , Putnam Investments , T Rowe Price Associates Inc , Mckinsey Global Institute , Ginkgo Bioworks , Soaring Eagle Acquisition , Synthetic Biotic , Soaring Eagle , Bloomberg News ,